Renalytix RNLXY
OTC RNLXY
$3.70 -0.09 (-2.37%)
At close: Nov 6, 2026 · 4:00 PM EST

Renalytix (RNLXY) Net Equity Issued and Repurchased (2021 - 2024)

Updated

Renalytix (RNLXY) posted Net Equity Issued and Repurchased of $8.46 million for fiscal Q4 2024 (quarter ended Jun 30, 2024).

Analysis

Renalytix (RNLXY) Net Equity Issued and Repurchased (2021 - 2024) Analysis & Trends

For FY2024 (ended Jun 30, 2024), Renalytix's Net Equity Issued and Repurchased came in at $13.53 million, down 33.3% from FY2023.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -14.2% (FY2019 to FY2024).
  • In prior fiscal years, Renalytix's Net Equity Issued and Repurchased was $20.3 million in FY2023 (+130.5%), $8.8 million in FY2022, $252,000 in FY2021 (-98.5%) and $17.28 million in FY2020 (-40.7%).
  • The fiscal Q4 2024 figure stands as the highest quarterly Net Equity Issued and Repurchased since fiscal Q3 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 8.46 Mn
Mar 31, 2023 20.30 Mn
Jun 30, 2022 8.80 Mn
Dec 31, 2021 111,000.00
Sep 30, 2021 86,000.00
Jun 30, 2021 252,000.00
API Access

Renalytix Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RNLXY&period=max&api_key=YOUR_API_KEY